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Background: Occlusion break surge during phacoemulsification cataract surgery can lead to potential surgical
complications. The purpose of this study was to quantify occlusion break surge and vacuum rise time of current
phacoemulsification systems used in cataract surgery.
Methods: Occlusion break surge at vacuum pressures between 200 and 600 mmHg was assessed with the Infiniti®
Vision System, the WhiteStar Signature® Phacoemulsification System, and the Centurion® Vision System using
gravity-fed fluidics. Centurion Active FluidicsTM were also tested at multiple intraoperative pressure target settings.
Vacuum rise time was evaluated for Infiniti, WhiteStar Signature, Centurion, and Stellaris® Vision Enhancement
systems. Rise time to vacuum limits of 400 and 600 mmHg was assessed at flow rates of 30 and 60 cc/minute.
Occlusion break surge was analyzed by 2-way analysis of variance.
Results: The Centurion system exhibited substantially less occlusion break surge than the other systems
tested. Surge area with Centurion Active Fluidics was similar to gravity fluidics at an equivalent bottle height.
At all Centurion Active Fluidics intraoperative pressure target settings tested, surge was smaller than with
Infiniti and WhiteStar Signature. Infiniti had the fastest vacuum rise time and Stellaris had the slowest. No
system tested reached the 600-mmHg vacuum limit.
Conclusions: In this laboratory study, Centurion had the least occlusion break surge and similar vacuum rise
times compared with the other systems tested. Reducing occlusion break surge may increase safety of
phacoemulsification cataract surgery.
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Cataract is a common vision-threatening condition that
accounts for approximately 40% to 50% of global blind-
ness; as such, an estimated 20 million cataract surgical
procedures are performed worldwide each year [1-3].
Clinicians prefer ultrasound phacoemulsification of the
crystalline lens because this approach has a low incidence
of complications and better uncorrected visual outcomes
than alternative treatment options for cataract removal
[2,4-6]. Phacoemulsification is performed using a phaco-
emulsifier aspirator (PEA). Most PEA systems use peri-
staltic pump technology that allows for independent
control of both the aspiration flow rate and vacuum limit
and can facilitate markedly lower flow rates than those
with nonperistaltic (ie, venturi) systems.* Correspondence: doug.fanney@alcon.com
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article, unless otherwise stated.During normal surgical conditions (ie, when the phaco-
emulsification tip is not occluded), the vacuum level in the
system’s fluidics is relatively low. When the tip becomes
occluded with aspirated material during surgery, the vacuum
in the system builds to a preset vacuum limit, which triggers a
vacuum pump shut-off. When an occlusion break occurs, the
vacuum accumulated in the aspiration lines returns to the
original low level. In many systems, particularly older systems, a
secondary effect referred to as occlusion break surge can occur.
Occlusion break surge (Figure 1) is defined as when ocular
fluid rushes into the aspiration port after the material occlud-
ing the phacoemulsification tip clears [7], filling the vacuum in
the tubing and causing a subsequent drop in intraocular
pressure [8]. Occlusion break surge can cause the anterior
chamber to shallow [9,10] or cause the iris or posterior capsuleentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Figure 1 Occlusion break surge: gravity-based systems. The schematic depicts (A) the anterior chamber and (B) IOP. During unobstructed
flow, aspiration and infusion are balanced to maintain a stable anterior chamber (A1) and IOP (B1). When the phaco tip becomes occluded with
nuclear material, fluid flow is blocked (A2) and IOP increases (B2). With occlusion break, vacuum stored in aspiration tubing during occlusion
(ie, no flow) can cause a sudden increase in aspiration rate (A3) and lead to a drop in IOP (B3). Infusion during unobstructed flow after occlusion
break leads to recovery of the anterior chamber (A4) and IOP (B4). IOP = intraoperative pressure.
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potential risk of posterior capsule rupture or iris trauma [5,11].
Ultrasound phacoemulsification technologies have evolved
over the last several years to improve surgical efficacy and
postsurgical outcome and to reduce complications of
cataract surgery [12]. The Centurion® Vision System (Alcon
Laboratories, Inc., Fort Worth, TX) is one of the newer PEA
systems; this system utilizes smaller aspiration tubing and a
cassette design with low compliance to minimize surge.
Minimizing compliance (ie, increasing the rigidity) of the
aspiration tubing can increase the rate of vacuum rise du-
ring occlusion (referred to as vacuum rise time), reaching
the preset vacuum limit more quickly [10]. Low-compliance
fluidic tubing also reduces occlusion break surge by decreas-
ing the potential energy via vacuum that is stored in the tub-
ing during occlusion [10]. The Centurion system also features
Active Fluidics™ designed to provide greater stability of intra-
operative pressure (IOP), minimizing IOP fluctuations that
occur during occlusion onset and postocclusion break events.
The objective of this study was to measure, in a
controlled laboratory setting, occlusion break surge and
vacuum rise time of current phacoemulsification systems
used in cataract surgery. This manuscript describes the test-
ing and determination of occlusion break surge area and
vacuum rise times of 4 PEA systems under surgically-
relevant operating conditions.Methods
This laboratory study used no human or animal subjects
and required no ethics approval.
Equipment
Standard equipment, including a Foxboro pressure/vacuum
transducer box (Invensys Systems, Inc., Plano, TX) and a
digital storage oscilloscope (Classic 6000; Gould Instrument
Systems, Cleveland, OH), was used for assessments of
occlusion break surge and vacuum rise time. The infusion
bottle height was set at the same actual elevation (90 cm)
above the transducer for all systems tested to avoid
potential differences in display height of the different
systems. To eliminate variability due to differences in
selected aspiration orifice cross-section areas, the same
phacoemulsification handpiece (OZil®; Alcon Labora-
tories), phacoemulsification tip type (30oR, 0.9 mm, non-
aspiration bypass system; Alcon Laboratories), and
matching infusion sleeve type were used for all testing
[13]. The fittings for irrigation and aspiration tubing on
each PEA system used a standard Luer interface that
enabled attachment of a single tip/handpiece configu-
ration to all systems. This setup ensured that resistance,
which is influenced by the area of the aspiration orifice,
was identical among PEA systems. After each system was
tuned and primed, the infusion fitting was tied to the
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The aspiration fitting of the system was connected to the
corresponding fitting located at the back of the handpiece.
Phacoemulsification systems and their respective flui-
dics and consumables are summarized in Table 1. Occlu-
sion break surge was assessed using Centurion, Infiniti®
(Alcon Laboratories), and WhiteStar® Signature (Abbott
Medical Optics [AMO], Santa Ana, CA) phacoemulsifi-
cation systems. Because flow rate cannot be directly
controlled in a venturi pump system, occlusion break
surge testing was performed using only peristaltic pump
systems. Vacuum rise times were evaluated for Centurion,
Infiniti, WhiteStar Signature, and Stellaris® Vision
Enhancement System (Bausch & Lomb, Rochester, NY).Occlusion break surge testing
The magnitude of the occlusion break surge was assessed
using a published test protocol [13]. To ensure reproducibil-
ity of results, 6 fluidic packs (ie, cassettes and tubing) were
tested per system, with each pack tested 3 times. Cassettes
were primed to remove entrapped air, and the ultrasound
tip and infusion sleeve were installed on the handpiece with
the aspiration line attached. The oscilloscope was calibrated
to the transducer; the vertical amplitude scale was set to
100 mV per division, and the horizontal time scale was set
to 200 milliseconds per division. For testing systems with
gravity fluidics, the irrigation bottle was placed at a height of
90 cm above the transducer midpoint. The Centurion sys-
tem was also tested with Active Fluidics across target IOP
settings ranging from 40 to 65 mmHg (equivalent to a bottle
height of approximately 54–88 cm H2O; Table 1). Centurion
system default parameters (vacuum rise = 0; IOP ramp= 1.0;
irrigation factor = 1.0) were used for testing; modifications
to these settings can be made directly from the front panel
of the PEA system.
All systems were tested at preset aspiration vacuum
limits of 200, 300, 400, 500, and 600 mmHg, with an as-
piration flow rate of 30 cc/minute for the peristaltic sys-
tems. The handpiece, transducer, and tubing were
positioned at the system target patient eye level, and theTable 1 Phacoemulsification systems tested
Phacoemulsification system Fluidics Consu
Centurion Active*; 40 (54), 50 (68),
55 (78), 65 (88.4)
Active
Centurion Gravity; 90 cm H2O Gravit
Infiniti Gravity; 90 cm H2O Intrep
WhiteStar Signature Gravity; 90 cm H2O OPO7
Stellaris Gravity; 90 cm H2O BL511
X = tested.
*Active Fluidics settings reflect target intraoperative pressure (IOP) and are presente
†Occlusion break surge was assessed using 6 fluidics packs per system, including tu
minimum of 3 fluidics packs per system.
‡IOP target of 65 mmHg only.test setup (Figure 2A), including tubing, test adapter,
handpiece, test chamber assembly, and transducer box,
was primed by activating the system’s foot pedal before
each experiment. Aspiration flow was started by activat-
ing the foot pedal, and the tubing portion between the
aspiration tubing test adapter and the handpiece was oc-
cluded using needle-nose pliers. Occlusion was released
when the preset vacuum limit was reached. The simu-
lated occlusion break surge event was captured with the
oscilloscope; surge area, which accounts for both ampli-
tude and duration of the surge, was determined from the
area under the surge curve and above the datum line
corresponding to positive chamber pressure of 20 mmHg.Vacuum rise time
Vacuum rise times were evaluated using a minimum of
3 packs per system, with packs primed on the respective
phacoemulsification systems. The oscilloscope vertical
amplitude scale was set to 500 mV per division, and the
horizontal time scale was set to 1 second per division.
The equipment setup for vacuum rise testing is depicted
in Figure 2B. As described elsewhere [13], testing of pha-
coemulsification systems was performed at a bottle
height of 90 cm for gravity-fed fluidics and target IOP of
65 mmHg for Active Fluidics (Centurion only; Table 1).
Vacuum rise times were evaluated at preset vacuum
pressure limits of 400 and 600 mmHg for all systems.
With the exception of Stellaris, which does not allow
control of aspiration flow rate, all systems were tested at
aspiration flow rates of 30 and 60 cc/minute. Occlusion
was formed by clamping the irrigation line within 1 inch
of the Luer connector, and aspiration flow was started
with the foot pedal. Vacuum was allowed to build for
approximately 8 seconds before the system was vented
by releasing the foot pedal; vacuum pressure level was
recorded at 0.5, 1, 1.5, 2, 3, 4, 5, and 6 seconds.Data analysis and statistics
Mean occlusion break surge area and standard deviation
(SD) were calculated for each phacoemulsification system.mables† Occlusion break Vacuum rise
Fluidics packs, P1423726 X X‡
y packs, P1423727H X X
id Plus gravity packs X X
0 tubing packs X X
1 venturi packs - X
d as IOP setting, mmHg (equivalent bottle height, cm H2O).
bing and cassettes, tested in triplicate. Vacuum rise was assessed using a
Figure 2 Experimental setup for (A) occlusion break surge and (B) vacuum rise time testing. Tubing was clamped at the sites indicated
with arrows. PEL = patient eye level; XDCR = transducer.
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each system. Statistical analysis was performed by 2-way




Occlusion break surge increased with increasing aspi-
ration vacuum for all phacoemulsification systems, with
the smallest surge areas observed at 200 mmHg and
largest surge areas observed at 600 mmHg. Across theaspiration vacuum pressure range tested, there was a sig-
nificant difference in surge area between systems (2-way
ANOVA, P < 0.05). Centurion produced substantially less
occlusion break surge with gravity and Active Fluidics
settings than the Infiniti and WhiteStar Signature; surge
was highest with the WhiteStar Signature (Figure 3). At
400 mmHg, mean ± SD occlusion break surge areas were:
WhiteStar Signature, 2.0 ± 0.28 mmHg∙second; Infiniti,
1.1 ± 0.12 mmHg∙second; Centurion (Active Fluidics,
IOP target 65 mmHg), 0.2 ± 0.06 mmHg∙second; and
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Figure 3 Occlusion break surge responses with increasing
aspiration vacuum. Gravity fluidics (bottle height, 90 cm) was used
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tested was largest at 600 mmHg. Surge areas were:
WhiteStar Signature, 4.8 ± 0.45 mmHg∙second; Infiniti,
4.1 ± 0.37 mmHg∙second; Centurion Active Fluidics, 1.3 ±
0.15 mmHg∙second; and Centurion gravity fluidics, 1.4 ±
0.12 mmHg∙second. Centurion active (IOP target 65 mmHg)
and gravity (90 cm H2O) fluidics performed similarly across
the range of aspiration vacuum pressures tested.
At each preset aspiration vacuum pressure tested,
occlusion break surge area predictably increased with
decreasing Centurion Active Fluidics IOP target settings
(Figure 4). This was most evident at higher aspiration
vacuum pressures (ie, 400, 500, and 600 mmHg). Surge
areas were similar with Active Fluidics target IOP
settings of 50, 55, and 65 mmHg and gravity fluidics
(90 cm H2O) at 200 and 300 mmHg (ranges, 0.04–0.06
and 0.05–0.13 mmHg, respectively). At 600 mmHg, all
Centurion Active Fluidics target IOP settings achieved200 300
IOP target of 40 mmHg (Equiv. 54 cm H2O)
IOP target of 50 mmHg (Equiv. 68 cm H2O)
IOP target of 55 mmHg (Equiv. 78 cm H2O)
IOP target of 65 mmHg (Equiv. approx. 90 cm H2O)

























Figure 4 Comparison of Centurion occlusion break surge
response. Gravity and Active Fluidics IOP target settings were used.
IOP = intraoperative pressure.smaller occlusion break surge areas (Figure 4) than the
gravity fluidics of Infiniti or WhiteStar Signature (Figure 3).
With Active Fluidics, surge areas were 3.6 ± 0.37 mmHg
with target IOP 40 mmHg; 2.7 ± 0.21 mmHg with
target IOP 50 mmHg; 2.1 ± 0.37 mmHg with target
IOP 55 mmHg; and 1.3 ± 0.15 mmHg with target IOP
65 mmHg.
Vacuum rise time
With the vacuum limit preset to 400 mmHg, Infiniti
had the fastest vacuum rise of the 4 systems tested
during occlusion at flow rates of 30 and 60 cc/minute; the
Stellaris, which does not enable flow rate control, had the
slowest (Figure 5). Infiniti exceeded the preset vacuum
limit at both tested flow rates (30 cc/minute, –410 mmHg;
60 cc/minute, –404 mmHg; both at 0.5 second). With
gravity fluidics, Centurion demonstrated a rate of
vacuum rise similar to that of Infiniti and did not
exceed the preset vacuum limit (30 cc/minute, –399 mmHg;
60 cc/minute, –400 mmHg; 0.5 second each). At a flow
rate of 60 cc/minute, vacuum rise times to 400 mmHg
were similar between phacoemulsification systems with
controllable flow rates.Time, seconds
B
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Figure 5 Vacuum rise times at a vacuum limit of 400 mmHg.
Testing was performed with flow rates of (A) 30 cc/minute and
(B) 60 cc/minute. Gravity fluidics (bottle height, 90 cm) was used
unless otherwise indicated. IOP = intraoperative pressure.
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WhiteStar Signature demonstrated the fastest initial vacuum
rise during occlusion (Figure 6). No system reached the vac-
uum limit of 600 mmHg at 30 or 60 cc/minute. The max-
imum vacuum reached at a flow rate of 30 cc/minute was
greatest with Infiniti (–595 mmHg, 1.5 seconds), followed by
WhiteStar Signature (–593 mmHg, 5.0 seconds), Centurion
with gravity fluidics (–587 mmHg, 2.0 seconds), and
Centurion with Active Fluidics (–582 mmHg, 2 seconds).
At 60 cc/minute, maximum vacuums achieved were
–598 mmHg (Infiniti, 0.5 second), –595 mmHg (WhiteStar
Signature, 1.5 seconds), –588 mmHg (Centurion with gra-
vity fluidics, 1 second), and –583 mmHg (Centurion with
Active Fluidics, 1.5 seconds). Stellaris reached –591 mmHg
at 2 seconds.
Discussion
Occlusion break surge occurs when potential energy via
vacuum build-up in the aspiration line and cassette
during phacoemulsification tip occlusion is suddenly
released when the occlusion clears. In this study, the
Centurion Vision System produced markedly less occlu-
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Figure 6 Vacuum rise times at a vacuum limit of 600 mmHg.
Testing was performed with flow rates of (A) 30 cc/minute and
(B) 60 cc/minute. Gravity fluidics (bottle height, 90 cm) was used
unless otherwise indicated. IOP = intraoperative pressure.particularly at higher vacuum pressures. This was true
whether gravity or comparable active Centurion fluidics
were tested. Surge areas with Centurion Active Fluidics
at a target IOP setting of 65 mmHg, which is equivalent
to 88.4 cm H2O, and Centurion gravity fluidics at a bot-
tle height of 90 cm H2O were similar at all aspiration
vacuum pressures tested. Across the tested range of as-
piration vacuum pressures, occlusion break surge with
Centurion Active Fluidics settings equivalent to bottle
heights of 54 to approximately 90 cm H2O was substan-
tially smaller than with Infiniti or WhiteStar Signature
gravity fluidics at 90 cm H2O. Vacuum rise times were
generally similar for Infiniti, WhiteStar Signature, and
Centurion at typical (30 cc/minute) and maximal
(60 cc/minute) aspiration flow rates; vacuum rise with
Stellaris, which does not have variable flow rate
control, was slowest.
Phacoemulsification system compliance involves the
system itself and its fluidic components, including aspi-
ration tubing and cassette [10,13]. Reducing compliance
of fluidics components is a key factor in managing
occlusion break surge [8]. Occlusion break surge with
Infiniti and WhiteStar Signature was comparable to that
described previously [13]. WhiteStar Signature had a
larger occlusion break surge than Infiniti, which is in
agreement with the finding that Infiniti was the more
compliant of the 2 systems in a laboratory setting [10].
In the typical working range of most cataract surgeries
(ie, 200 − 600 mmHg) [13] and an irrigation bottle height
of 90 cm H2O, surge areas with these systems were 2- to
7-fold and 3.5- to 20-fold higher, respectively, compared
with surge area with the Centurion system. With trad-
itional gravity fluidics, irrigation bottle height controls
fluid infusion pressure [8]. With occlusion break, faster
inflow is necessary to balance the ocular fluid outflow
that fills the vacuum created in aspiration lines during
occlusion, thereby reducing surge [14]. In this study,
even at the highest preset aspiration vacuum level
(600 mmHg) and lowest Active Fluidics irrigation fluid
pressure (IOP target 40 mmHg, equivalent to 54 cm
H2O), Centurion achieved decreased surge area com-
pared with the gravity fluidics of Infiniti and WhiteStar
Signature at 90 cm H2O. This was likely due to the
lower-compliance fluidics of Centurion compared with
the other systems tested. One effective approach to re-
duce occlusion break surge is to use a lower aspiration
vacuum limit, thus lowering the maximum potential
vacuum level in the aspiration fluidics.
Testing at vacuum limits of 400 and 600 mmHg and
with typical (30 cc/minute) and maximal (60 cc/minute)
flow rates provided information about the operational
capabilities of the phacoemulsification systems investi-
gated. Infiniti exceeded the 400-mmHg vacuum pressure
limit, and no system achieved the 600-mmHg limit.
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of vacuum rise to both limits, vacuum rise times were
similar among the systems and fluidics tested.
One strength of this study was that the previously
published laboratory setup and use of the same phacoe-
mulsification handpiece, tip, and sleeve for all systems
tested enabled assessment of the relationship between
each system’s fluidics and occlusion break surge without
confounding variables [13]. Additionally, multiple fluidic
cassettes were tested for each phacoemulsification sys-
tem and demonstrated the reproducibility of system per-
formance. The laboratory setup provided a standardized,
repeatable test method using controlled, clinically rele-
vant conditions. This study also included time as a factor
in the occlusion break experiments, examining both the
magnitude and duration of surge. Previous assessments
have generally focused on surge magnitude alone [9,14,15].
Conclusions
The Centurion system achieved less occlusion break
surge when compared with Infiniti and WhiteStar Signa-
ture systems. Surge areas with the Centurion using grav-
ity fluidics and a comparable Active Fluidics setting were
similar at all aspiration vacuum levels tested. Vacuum
rise times were similar for all the peristaltic systems
tested; however, the Stellaris system demonstrated con-
siderably slower vacuum rise than the other systems.
Phacoemulsification systems with lower postocclusion
surge may decrease the risk of complications during
cataract surgery, whereas rapid vacuum limit response
may increase efficiency.
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